St. Jude Medical Completes Endocardial Solutions Acquisition

St. Paul, MN based St. Jude Medical has finalized the purchase of Endocardial Solutions (ESI), also of St. Paul, for $272 million.

The stockholders of ESI, a maker of diagnostic and therapeutic tools used to treat atrial fibrillation, approved the $11.75-per-share agreement, making the company a wholly owned subsidiary of St. Jude Medical.

The sale gives St. Jude an expanded offering to treat atrial fibrillation, an abnormal heart rhythm that afflicts more than six million people worldwide. The companies had announced an agreement last September.